We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
Anti-Diabetic ícone

1.0 by Newthoughts dev


Sep 1, 2017

Sobre este Anti-Diabetic

Um aplicativo em antidiabéticos

APPLICATION PROVIDE KEY NOTES ON ANTI-DIABETICS

NewThoughts Developer will try to help you by providing android application on important key notes for the preparation of GPAT and various National level entrance examination exam.

Key notes would also useful for the preparation of B. Pharmacy and M. Pharmacy examination as well as for various National level examination.

M.Pharma is one of the most important degree to get higher posts in pharmaceutical industry. GPAT qualified candidates not only have advantage to receive scholarship over M.Pharm admission but have chances of placement in best companies of the world in the best pay scale.

* GPAT qualifiers are also eligible for NIPER-JEE.

* GPAT qualified candidates are also eligible for various government fellowships.

* GPAT qualified candidates are eligible for admission in Ph.D at various universities of India?

Key Words; GPAT, B. PHARMACY, M. PHARMACY,

Novidades da Última Versão 1.0

Last updated on Sep 1, 2017

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Traduzindo...

Informações Adicionais do Aplicativo

Última versão

Pedido Anti-Diabetic Atualização 1.0

Requer Android

2.3 and up

Available on

Obter Anti-Diabetic no Google Play

Mostrar mais

Anti-Diabetic Capturas de tela

Inscrever-se no APKPure
Seja o primeiro a ter acesso ao lançamento antecipado, notícias e guias dos melhores jogos e aplicativos para Android.
Não, obrigado
Inscrever-se
Inscreva-se com sucesso!
Agora você está inscrito no APKPure.
Inscrever-se no APKPure
Seja o primeiro a ter acesso ao lançamento antecipado, notícias e guias dos melhores jogos e aplicativos para Android.
Não, obrigado
Inscrever-se
Sucesso!
Agora você está inscrito em nossa newsletter.